Corporate information

Official name
Muroplex Therapeutics Incorporated
Registration country

Company type

A discovery platform technology based on an immuno-modulatory compound that can stimulate or suppress the autoimmune system.

Funding rounds


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials